Why is streptococcus pyogenes important to medical microbiology

NSAIDs may inhibit neutrophil function and enhance cytokine production In addition, their use may mask some of the early signs and symptoms of invasive GAS infections and has been associated with episodes of necrotizing fasciitis and toxic shock syndrome in patients with varicella P haryngitis : Tonsillectomy may help reduce the number of acute infections in children with recurrent GAS pharyngitis and is generally recommended for children who have 6 to 7 documented GAS infections in a given year or 3 to 4 infections in each of 2 years 8.

It may also be desirable as a method to eliminate the carrier state in a select group of patients such as those with a family history of rheumatic fever. The latter has not been well studied.

Roos et al. A cute Rheumatic Fever: Salicylates and steroids are very effective in suppressing the acute manifestations of rheumatic fever, but neither has been shown to proven chronic valvular rheumatic heart disease Corticosteroid therapy is only for patients with significant carditis, especially cardiomegaly or congestive heart failure.

After 2 - 3 weeks, a slow taper may begin, decreasing the daily dose at the rate of 5 mg every 2 - 3 days. The problem of bacteriologic and clinical failures in the treatment of GAS pharyngitis has led some investigators to suggest that all patients should receive a test of cure at the end of treatment.

The patient who is symptomatic and culture positive at the end of treatment for acute pharyngitis may represent either failed treatment or acquisition of a new strain of GAS and should receive further treatment.

Clearly, patients with previous rheumatic fever who have symptoms of strep throat should be re-cultured at the end of treatment. Development of an effective group A streptococcal vaccine continues to be of interest; currently, none are commercially available. Researchers have looked at the conserved region of the M protein since this region is shared by all serotypes of GAS and because long-term exposure to group A streptococci results in acquired immunity A vaccine incorporating the conserved region of the M protein of group A streptococcus may stimulate a rapid rise in protective antibodies, but may also stimulate development of cross-reactive antibodies that recognize heart tissue.

Because of these potential safety issues, recent efforts have been directed at developing a vaccine against certain epitopes of the M protein that do not cross-react with myocardial tissue, providing a safer vaccine for immunizations This strategy is not without its problems. To provide immunity against the or so known M-types of GAS, the vaccine would need to be polyvalent. Further, the vaccine composition would likely need to be changed periodically to reflect those M-types prevalent in the population.

Group A streptococci are highly contagious and epidemics of pharyngitis, impetigo, scarlet fever, rheumatic fever, post-streptococcal glomerulonephritis, bacteremia, puerperal sepsis, streptococcal toxic shock syndrome and necrotizing fasciitis have been described reviewed in The acquisition of GAS in the family environment poses problems for individuals in that environment who may have previously acquired rheumatic fever.

This issue is discussed in section III. In the hospital environment, group A streptococcus can spread rapidly to patients with surgical wounds, burns or chicken pox or post-partum patients. Strict adherence to infection control measures is crucial. Because there are over different M-types of GAS this means that nosocomial isolates should be saved for subsequent epidemiologic comparisons should additional cases be identified.

Performing M-typing or comparing RFLP patterns is extremely important to determine if these cases originated from a common source such as an employee who is a carrier of GAS.

Strict isolation procedures should be employed in patients who are admitted to hospitals with GAS infections. Close contacts of primary cases of severe invasive GAS infections are at greater risk than the general population for development of colonization or superficial infection. The risk for invasive infection is less, but still higher than the general population. The clinician managing such cases should consider the risk and safety of these contacts and may wish to prescribe penicillin V K or, in penicillin allergic patients, clindamycin.

In a situation such as military barracks, benzathine penicillin administered intramuscularly on a monthly basis has been very useful to prevent streptococcal pharyngitis and rheumatic fever. Group A streptococcus has the unique ability to cause both acute purulent infections and nonpurulent complications that develop days after an initial infection.

With a recognized increase in incidence and severity of invasive group A streptococcal infections and changes in the epidemiology of ARF, treatment of group A streptococcal infections has taken on even greater importance. While penicillin remains the mainstay of treatment, its use has recently been brought into question.

New antibiotics and new strategies for treatment are being evaluated, and a vaccine effective against group A streptococcus is being developed. Once thought to have been relegated to simple sore throats, group A streptococcus has returned to the forefront of infectious diseases. T able 1. Antibiotic MIC Reference Penicillin. Nosocomial group A streptococcal infections associated with asymptomatic health-care workers - Maryland and California. MMWR ; Outbreak of invasive group A streptococcal infections in a nursing home.

Lessons on prevention and control. Arch Intern Med ; Ballow M. Mechanisms of action of intravenous immune serum globulin therapy. Pediatr Infect Dis J ; Streptococcal pharyngitis in children: A comparison of four treatment schedules with intramuscular penicillin G benzathine. JAMA ; Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci. J Clin Microbiol ; Bisno AL. The resurgence of acute rheumatic fever in the United States.

Ann Rev Med ; Streptococcal infections in skin and soft tissues. N Engl J Med ; In vitro and in vivo effects of penicillin and clindamycin on expression of group A beta-hemolytic streptococcal capsule. Antimicrob Agents Chemother ; Activation of a kilodalton human endothelial cell matrix metalloprotease by Streptococcus pyogenes extracellular cysteine protease. Infect Immun ; Genetic and phenotypic diversity among isolates of Streptococcus pyogenes from invasive infections.

J Infect Dis ; Group A streptococcal meningitis. Clin Infect Dis ; Poststreptococcal glomerulonephritis in children: clinicopathological correlations and long-term prognosis. Pediatr Nephrol ; A virulence regulon in Streptococcus pyogenes. Clonal basis for resurgence of serious Streptococcus pyogenes disease in the s. Lancet ; An outbreak of invasive Group A streptococcal disease associated with high carriage rates of the invasive clone among school-aged children. JAMA ; 1 Congeni BL. Pediatric Ann ; In vitro susceptibility of recent North American group A streptococcal isolates to eleven oral antibiotics.

Antimicrobial susceptibilities of Streptococcus pyogenes isolated from respiratory and skin and soft tissue infections: United States LIBRA surveillance data from Diagn Microbiol Infect Dis ; Treatment of acute streptococcal pharyngitis and prevention of rheumatic fever: a statement for health professionals. Pediatrics ; Dajani AS. Current status of nonsuppurative complications of group A streptococci.

Dale JB. Multivalent Group A Streptococcal Vaccines. Invasive group A streptococcal infections in Ontario, Canada. Prognosis of children with poststreptococcal reactive arthritis. Spread of serious disease-producing M3 clones of group A streptococcus among family members and health care workers.

Group A beta-hemolytic streptococcal bacteremia: historical overview, changing incidence, and recent association with varicella. Emm typing and validation of provisional M types for group A streptococci. Emerg Infect Dis ; Toxic shock syndrome-associated staphylococcal and streptococcal pyrogenic toxins are potent inducers of tumor necrosis factor production.

Fischetti VA. Decline of erythromycin resistance of group A streptococci in Japan. Familial transmission of a serious disease-producing group A streptococcus clone: Case reports and review. Gerber MA. Effect of early antibiotic therapy on recurrence rates of streptococcal pharyngitis.

Antibiotic resistance in group A streptococci. Pediatr Clinics of North America ; Twice-daily penicillin in the treatment of streptococcal pharyngitis. Am J Dis Child ; Human heart-infiltrating T cell clones from rheumatic heart disease patients recognize both streptococcal and cardiac proteins.

Circulation ; Immunoreactivity of anti-streptococcal monoclonal antibodies to human heart valves: evidence for multiple cross-reactive epitopes. Am J Pathol ; Cytokine induction by viable group A streptococci: suppression by streptolysin O. Cytokine production by human mononuclear cells in response to streptococcal exotoxins.

Clin Res ; 39 2 A. Streptococcal toxic shock syndrome: synthesis of tumor necrosis factor and interleukin-1 by monocytes stimulated with pyrogenic exotoxin A and streptolysin O. Superantigens associated with staphylococcal and streptococcal toxic shock syndromes are potent inducers of tumor necrosis factor beta synthesis.

J Infect Dis ; 1 Hallas G. The production of pyrogenic exotoxins by group A streptococci. J Hyg Camb ; Resurgence of acute rheumatic fever. Transmission of Streptococcus pyogenes causing toxic shock-like syndrome among family members and confirmation by DNA macrorestriction analysis.

Epidemiologic analysis of group A streptococcal serotypes associated with severe systemic infections, rheumatic fever, or uncomplicated pharyngitis. Cleavage of Interleukin 1beta IL-1beta precursor to produce active IL-1 beta by a conserved extracellular cysteine protease from Streptococcus pyogenes. Klein JO. Management of streptococcal pharyngitis. Streptococcal outbreaks and erythrogenic toxin type A.

Zentralbl Bakteriol Mikrobiol Hyg ; Cellular and biochemical responses of human T lymphocytes stimulated with streptococcal M protein. Uvulitis in children. Pediatr Infect Dis ; Lancefield RC. A micro precipitin-technic for classifying hemolytic streptococci, and improved methods for producing antisera.

Proc Soc Exp Biol Med ; Current knowledge of type specific M antigens of group A streptococci. J Immunol ; Group A streptococcus mural endocarditis. Markowitz M. Changing epidemiology of group A streptococcal infections. Markowitz M, Kaplan EL. Rheumatic Fever. Martin DR. Laboratory evaluation of streptococci. The cell envelope of a Group A streptococcus is illustrated in Figure 2. The complexity of the surface can be seen in several of the electron micrographs of the bacterium that accompany this article.

Figure 2. Cell surface structure of Streptococcus pyogenes and secreted products involved in virulence. In Group A streptococci, the R and T proteins are used as epidemiologic markers and have no known role in virulence.

The group carbohydrate antigen composed of N-acetylglucosamine and rhamnose has been thought to have no role in virulence, but emerging strains with increased invasive capacity produce a very mucoid colony, suggesting a role of the capsule in virulence. The M proteins are clearly virulence factors associated with both colonization and resistance to phagocytosis. More than 50 types of S. The M protein found in fimbriae also binds fibrinogen from serum and blocks the binding of complement to the underlying peptidoglycan.

This allows survival of the organism by inhibiting phagocytosis. The streptococcal M protein, as well as peptidoglycan, N-acetylglucosamine, and group-specific carbohydrate, contain antigenic epitopes that mimic those of mammalian muscle and connective tissue. As mentioned above, the cell surface of recently emerging strains of streptococci is distinctly mucoid indicating that they are highly encapsulated.

These strains are also rich in surface M protein. The M proteins of certain M-types are considered rheumatogenic since they contain antigenic epitopes related to heart muscle, and they therefore may lead to autoimmune rheumatic carditis rheumatic fever following an acute infection. The capsule of S. This allows the bacterium to hide its own antigens and to go unrecognized as antigenic by its host.

The Hyaluronic acid capsule also prevents opsonized phagocytosis by neutrophils or mancrophages. Colonization of tissues by S. It is now realized that S. Autosuggest Results. View Table Download. Subscribe: Institutional or Individual. Username Error: Please enter User Name. Password Error: Please enter Password. Forgot Password? Pop-up div Successfully Displayed This div only appears when the trigger link is hovered over.

Please Wait. This site uses cookies to provide, maintain and improve your experience. Pyogenic Streptococci. Streptococcus pyogenes. Pharyngitis, impetigo, deep soft tissue infections; bacteremia; rheumatic fever, glomerulonephritis, toxic shock.

Streptococcus agalactiae. Neonatal sepsis and meningitis; bacteremia, UTIs, e meningitis in adults. Streptococcus dysgalactiae subspecies equisimilis ; others. Pharyngitis, pyogenic infections similar to group A streptococci.

Viridans Streptococci. M protein, lipoteichoic acid, and protein F are responsible for the attachment of the bacteria to host cells. M protein is also responsible for inhibiting opsonization by binding to complement regulators and to fibrinogen. M protein is the most important virulence factor for S. Other virulent factors include streptokinase, streptodornase, hyaluronidase, and streptolysins, which help in the invasion of tissues.

History and physical findings will vary depending upon the type of infection acquired; nonetheless, an accurate history and proper clinical evaluation are required to reach an accurate clinical diagnosis of S.

Sore throat is usually a major complaint in the case of streptococcus pharyngitis. The most common clinical findings for Streptococcal pharyngitis include sudden onset of fever, malaise, pharyngeal exudate, tender cervical lymphadenopathy and, enlarged tonsils.

In children, impetigo is one of the most common skin infections. Typically the itchy reddish rash appears around mouth or nose that becomes fluid-filled blister later on. Blisters rupture easily and are covered with honey-colored crust. The lesions are usually well-localized and affect exposed areas of the body: face and lower extremities. There are typically no systemic manifestations of the impetigo. Patient with scarlet fever usually presents with high-grade fever, sore throat, strawberry-like tongue, and a blanchable, papular, non-confluent rash.

The rash typically lasts for 7 to 10 weeks, follows by desquamation. Desquamation can only be observed on the palms and soles. Soft tissue invasive infections due to S. Necrotizing fasciitis due to group A streptococcus S.

Systemically or locally immunocompromised individuals are at increased risk for developing necrotizing fasciitis. Other risk factors include surgical procedures, burns, blunt trauma, minor laceration, and childbirth. Localized pain, necrosis of the infected skin lesion, swelling, redness, edema, increased heart rate, and fever are the typical manifestations of necrotizing fasciitis. In the advanced stage of the disease, a picture of septic shock can be present.

Streptococcus pyogenes , also known as group A streptococcus GAS is a leading cause of pharyngitis in children and adolescents. Clinicians should use clinical and epidemiological findings to determine the likelihood of GAS pharyngitis.

It is recommended to obtain throat cultures in children with negative RADT results to prevent the development of complications. The gold standard test for the detection of GAS is throat culture; however, it is not cost-effective and can delay the treatment.

The drug of choice for treatment of bacterial pharyngitis is oral penicillin for 10 days or IM benzathine penicillin. This treatment is cost-effective and has a narrow spectrum of activity. In patients with penicillin allergy, macrolides and first-generation cephalosporins can be used. Severe invasive S.

Streptococcal pharyngitis should be differentiated from throat infections due to parainfluenza virus, rhinovirus, coxsackievirus, adenovirus, etc , Mycoplasma species, Corynebacterium diphtheria , and Epstein-Barr virus.